Search

everythinglearnresearchcommunity

for

Search:↓

People with polycystic ovary syndrome often have low levels of vitamin D.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Low zinc levels may be linked to the return of gynecologic cancers.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Female pattern hair loss is common in women with polycystic ovarian syndrome.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Gynecologists should learn about transgender care to provide the best service.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.